Find a Drug
Advanced Search

Professional

Nasalide

Patient Information
font size

PATIENT INFORMATION

Information for Patients:   Patients should use NASAREL at regular intervals since its effectiveness depends on its regular use. Patients should take the medication as directed and should not exceed the prescribed dose. A decrease in symptoms can be expected to occur within a few days of initiating therapy in allergic rhinitis patients. Patients should contact their physician if the condition worsens, if sneezing or nasal irritation occurs, or if symptoms do not improve by 3 weeks.

Persons taking immunosuppressant doses of corticosteroids should be warned to avoid exposure to chicken pox or measles. Patients should also be advised that if they are exposed, medical advice should be sought without delay.

For proper use of this unit and to attain maximum improvement, the patient should read and follow the accompanying Patient Instructions carefully.

Brand Name: Nasalide
Generic Name: Flunisolide (Nasal Spray)

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Bookmark this page:


Allergies & Asthma

Improve treatments & prevent attacks.

WebMD Symptom Checker - Start Here Ringworm Slideshow: Watch and Learn

Asthma and OzoneAsthma and Ozone
Researchers are trying to find out exactly why ozone has an impact on asthma and what to do about it. See more WebMD Videos »